The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Beneficial Metabolic Effects of Prompt Surgical Treatment in Patients with an Adrenal Incidentaloma Causing Biochemical Hypercortisolism
Abstract
CONTEXT: In patients with adrenal incidentalomas, subclinical hypercortisolism (SH) is associated with an increased prevalence of the metabolic syndrome. The effect of surgical/conservative approach is debated. OBJECTIVE: The objective of the study was to determine the effect of the surgical and conservative approaches on the metabolic syndrome in patients with adrenal incidentalomas. DESIGN: This was a retrospective longitudinal study (18-48 months follow-up). SETTING: The study was conducted on an in- and outpatient basis. PATIENTS: One hundred eight patients with adrenal incidentalomas were studied for the presence of SH, which was diagnosed in the presence of more than two of the following: urinary free cortisol greater than 70 microg per 24 h (193 nmol per 24 h), cortisol after 1 mg dexamethasone suppression test greater than 3.0 microg/dl (83 nmol/liter), ACTH less than 10 pg/ml (2.2 pmol/liter). INTERVENTIONS: Surgery was performed in 25 patients with SH (group TrSH+) and 30 without SH (group TrSH-), whereas the conservative approach was chosen by 16 patients with SH (group UntrSH+) and 37 without SH (group UntrSH-). MAIN OUTCOME MEASURES: During the follow-up, the improvement/worsening of body weight, blood pressure, or glucose and cholesterol levels was defined in the presence of a greater than 5% weight decrease/increase and following the European Society of Cardiology or the Adult Treatment Panel III criteria, respectively. RESULTS: In group TrSH+, weight, blood pressure, and glucose levels improved (32, 56, and 48%, respectively) more frequently than in group UntrSH+ (12.5%, P = 0.05; 0.0%, P < 0.0001; 0.0%, P = 0.001; and 0.0%, P = 0.0014, respectively). In group UntrSH+, blood pressure, glucose, and low-density lipoprotein levels worsened more frequently (50.0, 37.5, and 50.0%, respectively) than in group TrSH+ (0.0%, P < 0.0001; 0.0%, P = 0.001; and 20.0%, P = 0.05, respectively). CONCLUSIONS: Regarding the various components of the metabolic syndrome, in patients with adrenal incidentalomas and SH, surgery is beneficial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metabolic improvement after adrenalectomy, including weight loss, blood pressure lowering, glucose tolerance, lower lipids, and beneficial effects on bone have been reported (230,267).”
From Adrenal incidentaloma (2020) · cites this paper as [230]
In the citing paper
“Several studies have reported the outcome of surgical intervention but most involve small numbers and are retrospective, uncontrolled, and lack randomization (230,243,250-253,255) (Table 7).”
From Adrenal incidentaloma (2020) · cites this paper as [230]
In the citing paper
“Few studies evaluated the accuracy of the SH diagnosis before surgery to predict the improvement after surgery and, therefore, to address the treatment of choice in the individual subject (18,46,61,93).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [61]
In the citing paper
“This is of utmost importance because in several studies some of the surgically treated patients without SH experienced improvement of some metabolic endpoints (18,46,61,93).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [61]
In the citing paper
“On the contrary, in surgically untreated SH patients, blood pressure, glucose, and cholesterol levels worsened more frequently (50.0, 37.5, and 50.0%, respectively) than in surgically treated patients (0, 0, and 24%, respectively) (61).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [61]
In the citing paper
“In a retrospective, nonrandomized study, we reported that in 25 surgically treated SH patients, body weight, blood pressure, and glucose levels improved (32, 56, and 48%, respectively) more frequently than in untreated SH subjects (12.5, 0.0, and 0.0%, respectively) (61).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [61]
In the citing paper
“Similarly, because in some patients with SH not operated on, bone mineral density, fasting glucose, blood pressure, and cholesterol levels have been shown to worsen during follow-up (49, 61)”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [61]
In the citing paper
“the available data suggest a possible deleterious role of SH, at least on glucose and bone metabolism and on hypertension, even in patients adequately followed up with antihypertensive and antidiabetic medical therapy (61).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [61]
In the citing paper
“These uncertainties, in turn, bring into question the real clinical importance of SH itself and the need of a surgical treatment in these patients instead of the optimization of medical therapy (61).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [61]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
Bovio, S., Cataldi, A., Reimondo, G., Sperone, P., Novello, S., Berruti, A., Borasio, P., Fava, C., Dogliotti, L., Scagliotti, G. V., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344099 · Cited by 712
Kratz (2004) · doi:10.1056/nejmcpc049016 · Cited by 593
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–190 of 190
Wang, D., Ji, Z., Li, H., & Zhang, Y. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170531 · Cited by 16
“Therefore, surgery or a more conservative approach is controversial for adrenal incidentaloma in clinical practice [6, 11,12].”
Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
Altieri, B., Muscogiuri, G., Paschou, S. Α., Vryonidou, A., Casa, S. D., Pontecorvi, A., Faßnacht, M., Ronchi, C. L., & Newell-Price, J. D. C. (2018) · Endocrine · doi:10.1007/s12020-018-1696-z · Cited by 16
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome
Araujo-Castro, M., Lamas, C., Nowak, E., Newell-Price, J. D. C., Reincke, M., & Castinetti, F. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf042 · Cited by 19
Utsumi, T., Iijima, S., Sugizaki, Y., Mori, T., Somoto, T., Kato, S., Oka, R., Endo, T., Kamiya, N., & Suzuki, H. (2023) · International Journal of Urology · doi:10.1111/iju.15218 · Cited by 15
Delibaşı, T., Karbek, B., Bozkurt, N. Ç., Çakır, E., Güngüneş, A., Ünsal, Ö. Ö., Aslan, M. S., & Çakal, E. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000053 · Cited by 15
Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing’s syndrome
Tateishi, Y., Kouyama, R., Mihara, M., Doi, M., Yoshimoto, T., & Hirata, Y. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0204 · Cited by 15
Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess
Kelsall, A., Iqbal, A., & Newell-Price, J. D. C. (2020) · Gland Surgery · doi:10.21037/gs.2019.11.19 · Cited by 15
“Several studies have reported the cardiovascular benefits of adrenalectomy in AI (21,22,24) although others have shown no significant effect (20).”
BackgroundResultPathophysiology, Diagnosis, and Treatment of Mineralocorticoid Disorders
Magill, S. B. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130042 · Cited by 15
“Even though there is no universal agreement that autonomous cortisol production is a true syndrome (342,382), there is emerging evidence that it is a true clinical entity and if diagnosed, appropriate treatment should be rendered (49, 311).”
Cardiac Hypertrophy and Related Dysfunctions in Cushing Syndrome Patients—Literature Review
Kanzaki, A., Kadoya, M., Katayama, S., & Koyama, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237035 · Cited by 16
Ren, X., Nan, M., & Zhang, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1399311 · Cited by 14
When to Intervene for Subclinical Cushing's Syndrome
Hsieh, L. B., MacKinney, E. C., & Wang, T. S. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.011 · Cited by 14
Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
Szychlińska, M., Baranowska-Jurkun, A., Matuszewski, W., Wołos-Kłosowicz, K., & Bandurska-Stankiewicz, E. M. (2020) · Medicina · doi:10.3390/medicina56020069 · Cited by 14
Wang, D., Li, H., Zhang, Y., Wang, L., & Ji, Z. (2018) · Surgical Laparoscopy Endoscopy & Percutaneous Techniques · doi:10.1097/sle.0000000000000585 · Cited by 13
Minimally invasive approach to the adrenal gland in obese patients with Cushing’s syndrome
Ortenzi, M., Balla, A., Ghiselli, R., Vergari, R., Silecchia, G., Guerrieri, E., Paganini, A. M., & Guerrieri, M. (2019) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645706.2018.1536669 · Cited by 13
“e hypertension or even morbid obesity) [10,13].”
BackgroundÜnal, A. D., Aytürk, S., Aldemir, D., & Tütüncü, N. B. (2016) · International Journal of Endocrinology · doi:10.1155/2016/8519362 · Cited by 11
Adrenal incidentaloma: differential diagnosis and management strategies
Morelli, V., & Palmieri, S. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02868-7 · Cited by 12
Self-citationBilateral adrenal incidentaloma with subclinical hypercortisolemia: indications for surgery
Papierska, L., Ćwikła, J. B., Rabijewski, M., Glinicki, P., Otto, M., & Kasperlik-Zaluska, A. A. (2014) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2347 · Cited by 10
Approach to the Patient with an Incidental Adrenal Mass
He, X., Peter, P. R., & Auchus, R. J. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.009 · Cited by 11
The impact of mild autonomous cortisol secretion and proposed interventions
Iriarte-Durán, M. B., Donato, S., Herrera-Martínez, A. D., Vega, A., Casinello, J. M. J., Marazuela, M., & Castro, M. A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2480704 · Cited by 10
Παππά, Θ., Papanastasiou, L., Kaltsas, G., Markou, Α., Tsounas, P., Androulakis, I. I., Tsiavos, V., Zografos, G., Vamvakidis, K., Samara, C., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2874 · Cited by 9
Mintziori, G., Georgiou, T., Anagnostis, P. G., Adamidou, F., Efstathiadou, Z. A., Panagiotou, A., & Kita, M. D. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0630-1397 · Cited by 9
“Only five out of twelve patients with autonomous cortisol secretion underwent adrenalectomy in the aforementioned study, however this improvement in metabolic factors after surgery has been confirmed by other cohort studies [22, 23].”
ResultChen, A., & Burt, M. G. (2022) · Clinical Endocrinology · doi:10.1111/cen.14850 · Cited by 11
“possible autonomous cortisol secretion have generally reported an improved glycometabolic profile, although there are some conflicting results.(20,21,26,53,55) However, the biochemical criteria used to define”
BackgroundResultSubclinical Cushing's syndrome
Tsinberg, M., Liu, C., & Duh, Q. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23143 · Cited by 9
Villéon, B. D. L., Bonnet, S., Gouya, H., Groussin, L., Tenenbaum, F., Gaujoux, S., & Dousset, B. E. (2016) · Surgery · doi:10.1016/j.surg.2016.03.008 · Cited by 9
Poonuru, S., Findling, J. W., & Shaker, J. L. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3712-6 · Cited by 9
“There is also evidence that surgical treatment of subclinical hypercortisolism caused by adrenal adenomas results in metabolic benefits [25].”
BackgroundThe Diagnosis of Cushing’s Syndrome
Nieman, L. K. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_4 · Cited by 9
Ueland, G. Å., Methlie, P., Heie, A., Stokland, A. M., Dahle, A. L., Sævik, Å. B., Løvås, K., & Husebye, E. S. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad076 · Cited by 8
Adrenal incidentalomas and subclinical Cushing’s syndrome
Abdelmannan, D. K., & Aron, D. C. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9141-5 · Cited by 8
“Most recently, a larger study (108 patients) was reported by Chiodini et al [ 44 ].”
BackgroundKhawandanah, D., El-Asmar, N., & Arafah, B. M. (2018) · Endocrine · doi:10.1007/s12020-018-1769-z · Cited by 8
Ueland, G. Å., Ragnarsson, Ó., Heie, A., Kjellbom, A., Lindgren, O., Muth, A., Palazzo, F. F., Poulsen, P. L., Rolighed, L., Thordarson, H. B., et al. (2025) · Endocrine Connections · doi:10.1530/ec-25-0361 · Cited by 7
GH secretion reserve in subclinical hypercortisolism
Palmieri, S., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Cairoli, E., Zhukouskaya, V. V., Beck‐Peccoz, P., Scillitani, A., & Chiodini, I. (2013) · Pituitary · doi:10.1007/s11102-013-0528-7 · Cited by 7
Self-citationTuna, M. M., Dogan, B. A., Karakılıç, E., Arduç, A., Işık, S., Yılmaz, F. M., Topçuoğlu, C., Berker, D. S., & Güler, S. (2014) · PubMed · Cited by 7
Reliability of adrenal computed tomography in predicting the functionality of adrenal incidentaloma
Mansour, A., Al-Waeli, D. K., & Haddad, N. (2020) · Nigerian Postgraduate Medical Journal · doi:10.4103/npmj.npmj_156_19 · Cited by 7
İmga, N. N., Topçuoğlu, C., Berker, D. S., & Turhan, T. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.07.002 · Cited by 7
Persistent Comorbidities in Cushing’s Syndrome after Endocrine Cure
Resmini, E. (2014) · Advances in Endocrinology · doi:10.1155/2014/231432 · Cited by 7
“, diabetes, hypertension, and osteoporosis) [21–25] which may improve after the recovery [3, 26, 27].”
BackgroundWang, Q., Lv, D., Wen, J., Zhou, H., Jia, M., Li, J., Du, H., & Shuang, W. (2025) · BMC Cancer · doi:10.1186/s12885-025-13774-0 · Cited by 6
“Although some observational studies have reported elevated LDL levels in patients with benign adrenal tumors [82, 83], this discrepancy may be attributable to cortisol ‐ induced alterations in cholesterol metabolism.”
Adrenal Incidentaloma: From Silent Diagnosis to Clinical Challenge
Mirică, A., Tilici, D.-M., Păun, D. L., Arnautu, A. M., Nimigean, V., & Paun, S. C. (2025) · Biomedicines · doi:10.3390/biomedicines13092298 · Cited by 5
“There have been reports of metabolic improvement following adrenalectomy, including weight loss, reduced blood pressure, improved glucose tolerance, and decreased cholesterol levels [69].”
Kuzu, İ., Zuhur, S. S., Demir, N., Aktas, G., Öztürk, F. Y., & Altuntaş, Y. (2016) · Endokrynologia Polska · doi:10.5603/ep.a2016.0028 · Cited by 5
“In a few studies it was shown that, although there was no biochemical proof of SCS prior to surgery, some of the comorbidities of SCS improved following surgery in some patients with adrenal incidentaloma [4, 6].”
BackgroundAdrenal Causes of Cushing’s Syndrome
Cavagnini, F., & Giraldi, F. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00103-7 · Cited by 5
Metabolic and cardiovascular impact of non-functioning adrenal adenomas: A clinical dilemma
Yener, S. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.02.005 · Cited by 5
“grouped 108 subjects according to hormonal and follow-up status [31].”
BackgroundTurcu, A. F., & Auchus, R. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_10 · Cited by 4
Cardiovascular and metabolic consequences in patients with asymptomatic adrenal adenomas
Hamidi, O. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000628 · Cited by 4
“improvement in cardiovascular risk factors in some patients with NFA, although more data are needed to understand the role of surgery for NFA [13,16,19].”
BackgroundYılmaz, N. (2021) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2021.479 · Cited by 4
Sato, H., Imamura, Y., Sakamoto, S., Sugiura, M., Arai, T., Yamamoto, S., Takeuchi, N., Sazuka, T., Nakamura, K., Nagano, H., et al. (2020) · International Journal of Urology · doi:10.1111/iju.14445 · Cited by 4
Approaching Primary Aldosteronism as a Common Disease
Auchus, R. J. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.08.014 · Cited by 3
Carey, R. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2162 · Cited by 3
Cushing Syndrome: Presentation, Diagnosis, and Treatment, Including Subclinical Cushing Syndrome
Neychev, V. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_9 · Cited by 3
Unger, N. (2018) · Der Chirurg · doi:10.1007/s00104-018-0739-6 · Cited by 3
Bilateral Adrenal Nodules Presenting With Mild Autonomous Cortisol Secretion
Sandooja, R., Hamidi, O., Zhang, C. D., Dogra, P., Athimulam, S., Rahimi, L., Villavicencio, C. A., Chacko, S. R., Young, W. F., & Bancos, I. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.06.019 · Cited by 2
Gagliardi, L. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 2
Inoue, S., Hayashi, T., Teishima, J., & Matsubara, A. (2020) · Urologia Internationalis · doi:10.1159/000508765 · Cited by 1
Kuznetsov, N. S., & Tihonova, O. V. (2015) · Endocrine Surgery · doi:10.14341/serg2015122-34 · Cited by 1
“[23] показано, что после проведения адреналэктомии улучшение показателей гликемии и артериального давления наблюдается не только у пациентов с ССК, но и у пациентов с гормонально-неактивными образованиями надпочечников.”
Takayanagi, R., Kawate, H., & Yanase, T. (2012) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.101.941 · Cited by 1
Capatina, C. A.-M., Baciu, I. F., Greere, D., Caragheorgheopol, A., & Poiană, C. (2018) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2018-0008 · Cited by 1
“Also, glycemic control is significantly improved and diabetes mellitus may completely remit in certain cases after successful reversal of hypercortisolism [10].”
BackgroundSecondary Causes of Adipose Tissue Weight Gain
Hurley, D. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_10 · Cited by 1
Allolio, B., Nies, C., Moll, R., Klose, K., Kann, P. H., Pfestroff, A., Waldmann, J., Bartsch, D. K., Lehnert, H., Dralle, H., et al. (2012) · Springer eBooks · doi:10.1007/978-3-642-14285-7_4 · Cited by 1
Diabetes mellitus type 2: a new indication for hypercortisolism screening?
Волкова, Н. И., Antonenko, M. I., & Ganenko, L. A. (2012) · Diabetes Mellitus · doi:10.14341/2072-0351-5545 · Cited by 1
Management of adrenal incidentaloma
Kaštelan, D. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.75 · Cited by 1
Relevance and perspective concept of investigation of subclinical Cushing syndrome.
Kuznetsov, N. S., Latkina, N. V., & Kaminarskaya, Y. A. (2016) · Endocrine Surgery · doi:10.14341/serg2016113-22 · Cited by 1
Advances in our understanding of the prognosis of adrenal incidentaloma
Mackay, I., & Aspinall, S. R. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1233055 · Cited by 1
“Likewise, Chiodini showed that adrenalectomy improved BMI, hypertension, and fasting glucose in 25 patients with AI and SH compared to 16 controls managed conservatively [79].”
MethodLirov, R., & Gauger, P. G. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_26 · Cited by 1
Auchus, R. J. (2014) · Encyclopedia of the Neurological Sciences · doi:10.1016/b978-0-12-385157-4.01207-0 · Cited by 1
Adrenal Incidentalomas and Arterial Hypertension
Παππά, Θ., Kaltsas, G., Piaditis, G. P., & Chrousos, G. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_6
ADRENAL INCIDENTALOMAS: DIAGNOSIS AND MANAGEMENT
Grineva, E. N., Belousova, L., & Basek, I. V. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-6-532-537
Long term follow-up of benign functional adrenocortical tumors in the era of robotic surgery
Nilsson, M., Almqvist, M., & Nordenström, E. (2012) · Endocrinology Studies · doi:10.4081/es.2012.e4
Bilateral adrenal tumors with subclinical hypercortisolemia. To operate or observe
Papierska, L., & Nowak, K. M. (2014) · Postępy Nauk Medycznych
L'incidentalome surrénalien, étude du statut métabolique et de la fibrinolyse
Thebert, J. (2015) · HAL
Papierska, L., Glinicki, P., Otto, M., & Kasperlik-Zaøuska, A. (2015)
Operative Techniques for Adrenal Neoplasms
Patel, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_13
Adrenal Cushing’s Syndrome: Updates on Overt and Mild Hypercortisolism
Escobar, J. S., Ravikumar, A., & Levine, A. C. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_10
Kang, M., Baek, M., Lee, J., & Jeong, B. C. (2017) · Journal of Urologic Oncology · doi:10.22465/kjuo.2017.15.3.137
“Iacobone et al.8 have demonstrated efficacy of LA in inducing remission of hormonal abnormalities and improvement of blood pressure, glycemic control, body weight, and health-related quality of life in patients with SCS. Chiodini et al.16 have reported that adrenalectomy was more beneficial for patients with SCS compa…”
BackgroundCardiovascular Risk Factors in Patients with Non-functional Adrenal Incidentalomas
Vardal, T. O. (2020) · Southern Clinics of Istanbul Eurasia · doi:10.14744/scie.2020.50455
Hamidi, M., Mavros, M. N., Devon, K. M., Kulkarni, G. S., Law, C., Urbach, D. R., Hallet, J. I., & Pasternak, J. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-48363-0_1 · Cited by 1
Subklinischer) Hyperkortisolismus als mögliche endokrine Hypertonieursache
Stepan, V. M. (2013)
Den glukokortikoidinduzierten Diabetes auf dem Schirm behalten
Konz, K. (2021) · Info Diabetologie · doi:10.1007/s15034-021-3729-6
Subclinical Cushing’s syndrome: lots of questions — little answers
Rybakov, S. I. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.6.2021.243216
Den glukokortikoidinduzierten Diabetes auf dem Schirm behalten
Konz, K. (2021) · CME · doi:10.1007/s11298-021-2210-0
Long term follow-up of benign functional adrenocortical tumors in the era of robotic surgery
Nilsson, M., Almqvist, M., & Nordenström, E. (2012) · Endocrinology Studies · doi:10.4081/4336
Baudry, C., Waintrop, C., & Mosnier-Pudar, H. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)53860-0
Nockel, P. J., Lakis, M. E., & Kebebew, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64279-4
Nunes, M.-L., & Tabarin, A. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)53091-4
Nockel, P. J., Lakis, M. E., & Kebebew, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00230-2
FIGURES 45 in Two new species of Ascidae (Acarina: Mesostigmata) from India
Bhattacharyya, A. K. (2003) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.157114
Surgical issues for a patient with Cushing's syndrome: Techniques, complications, and recovery
Dinerman, A. J., & Nilubol, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00009-0
Devaraja, V., Rajoo, S., Valayatham, V. M., & Hui, F. S. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.01.5143
“10,27 Additionally, Barzon et al., documented a 50-70% higher prevalence of dyslipidemia and central obesity in MACS patients, likely due to cortisol's role in fat redistribution and lipid metabolism.”
Chongvoranond, P., Chatchomchuan, W., Wanothayaroj, E., Butadej, S., Nakasatien, S., Himathongkam, T., & Thewjitcharoen, Y. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.01.6239
Wu, B., Tian, X., Fang, C., Han, M., Jin, S., Liu, Q., Zhang, Y., Qiao, Y., & Liu, Y. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.09.004
Metadata
- Authors
- Chiodini, I., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., Pellegrini, F., Copetti, M., Beck-Peccoz, P., Arosio, M., Ambrosi, B., Trischitta, V., & Scillitani, A.
- Affiliations
- Department of Medical Sciences (I.C., V.M., A.S.S., C.E.-V., P.B.-P., M.A.), San Donato Institute, San Donato Milanese, 20122 Milan, Italy
- Casa Sollievo della Sofferenza (IT)
- Ospedale San Giuseppe (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Milan (IT)
- Corresponding author
- Chiodini, Iacopo
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2736-2745
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2139061427
- Semantic Scholar
- def83fa11c628e121412927601cdf15281915ed5
- Cited by
- 191
- References
- 43
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 2 · 2023: 10 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 14 · 2017: 8 · 2016: 18 · 2015: 19 · 2014: 18 · 2013: 12 · 2012: 21
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal incidentaloma, subclinical hypercortisolism, metabolic syndrome, adrenalectomy, conservative treatment, body weight, blood pressure, glucose, cholesterol, urinary free cortisol, ACTH, dexamethasone suppression test
- MeSH terms
- Adrenal Gland Neoplasms, Adrenocorticotropic Hormone, Adult, Aged, Blood Glucose, Blood Pressure, Body Weight, Cholesterol, Cushing Syndrome, Dexamethasone, Female, Follow-Up Studies, Humans, Hydrocortisone, Cholesterol, LDL, Longitudinal Studies, Male, Middle Aged, Thyrotropin, Treatment Outcome, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
